Dr. Unger is a serial entrepreneur and has founded multiple biotech companies. His first company, ImaRx Pharmaceutical, developed 3 FDA approved drugs and was acquired by DuPont yielding a > 20x ROI. Dr. Unger’s second company, ImaRx Therapeutics, went public and performed clinical trials using a pioneering new technology to treat stroke. Dr. Unger co-founded NuvOx, in-licensed the core patents and obtained ownership of the regulatory documents for NuvOx’s key product. Dr. Unger is an inventor on over 120 issued US patents. Dr. Unger currently also serves as CEO of Microvascular Therapeutics. He is a board-certified radiologist and is Professor Emeritus of Medical Imaging at the University of Arizona.